Low-dose Atropine Eye Drops to Reduce Progression of Myopia in Children in the United Kingdom

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

289

Participants

Timeline

Start Date

April 3, 2019

Primary Completion Date

February 29, 2024

Study Completion Date

February 2, 2027

Conditions
Myopia
Interventions
DRUG

Atropine Sulfate

Atropine sulfate 0.01% eye drops which consist of 10mls of a clear colourless solution of atropine sulfate 0.01% w/v and benzalkonium chloride 0.01% w/v in sterile water.

OTHER

Placebo

Placebo eye drops which consist of 10mls of a clear colourless solution of benzalkonium chloride 0.01% w/v in sterile water.

Trial Locations (4)

BT9 7AB

Northern Ireland Clinical Research, Belfast

B4 7ET

Aston University Eye Clinic, Birmingham

CB1 1PT

Anglia Ruskin University Eye Clinic, Cambridge

G4 0BA

Centre for Living (Glasgow Caledonian University), Glasgow

All Listed Sponsors
lead

Belfast Health and Social Care Trust

OTHER

NCT03690089 - Low-dose Atropine Eye Drops to Reduce Progression of Myopia in Children in the United Kingdom | Biotech Hunter | Biotech Hunter